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Abstract
Background and Aim: The liver has a unique capacity to regenerate upon exposure to
viral infections, toxic reactions and cancer formation. Liver regeneration is a complex
phenomenon in which several factors participate during its onset. Cellular proliferation is
an important component of this process and the factors that regulate this proliferation have
a vital role. FLT3, a well-known hematopoietic stem cell and hepatic lineage surface
marker, is involved in proliferative events of hematopoietic stem cells. However, its con-
tribution to liver regeneration is not known. Therefore, the aim of this study was to clone
and examine the role of FLT3 during liver regeneration in rats.
Methods: Partial cDNA of rat homolog of FLT3 gene was cloned from thymus and the
tissue specific expression of this gene at mRNA and protein levels was examined by
RT-PCR and Western blot. After treating with 2-AAF and performing hepatectomy in rats
to induce progenitor-dependent liver regeneration, the mRNA and protein expression
profile of FLT3 was investigated by real-time PCR and Western blot during liver regenera-
tion. In addition, cellular localization of FLT3 protein was determined by immunohis-
tochemistry.
Results: The results indicated that rat FLT3 cDNA has high homology with mouse and
human FLT3 cDNA. It was also found that FLT3 is expressed in most of the rat tissues and
during liver regeneration. In addition, its intracellular localization is altered during the late
stages of liver regeneration.
Conclusion: The FLT3 receptor is activated at the late stages of liver regeneration and
participates in the proliferation response that is observed during progenitor-dependent liver
regeneration.
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Introduction
The liver has a great capacity to regenerate after the loss of hepa-
tocytes by toxic or viral injury or secondary to liver resection1,2
with a process known as liver regeneration, as illustrated by the
ancient Greek legend of Prometheus. Liver regeneration is a
complex physiological response, and a series of reactions must
take place for survival of the organism. Oval cells have a central
role in progenitor-dependent liver regeneration and they are acti-
vated to proliferate when the replication and functional capacity of
the mature hepatocytes is disrupted.3,4 Oval cells are regarded as
bipotential precursors for the two hepatic parenchymal cell lin-
eages, hepatocytes and bile duct cells, and have lineage options
similar to those displayed by hepatoblasts in early stages of liver
development.5–8 Several models in rodents have been established
for triggering oval cell proliferation.9 In the model of
2-acetaminofluorene (2-AAF) treatment and partial hepatectomy
(PH) operation (2-AAF/PH), the proliferating oval cells form
irregular duct-like structures that are connected with preexisting
bile ducts.10 The continuous administration of a low concentration
of 2-AAF suppresses the proliferation of hepatocytes and at the
middle point of the treatment the animals are subjected to a
massive loss of hepatocytes by PH. When the hepatocytes do not
respond to growth signals, there is rapid growth of the oval cells.11
Oval cells express specific proteins, one of which is thought to
be FLT3.12–14 FLT3 encodes an receptor tyrosine kinase (RTK) of
993 amino acids that belongs to the RTK subclass III family and is
a well-known hematopoietic stem cell marker.15,16 Unstimulated
FLT3 receptors are in monomeric form in the plasma membrane.
In this inactive state, the conformation of the receptor might result
in steric inhibition of dimerization and exposure of phosphoryl
acceptor sites in the tyrosine kinase domain (TKD) by the jux-
tamembrane domain.16 After stimulation with the ligand FLT3L,
membrane-bound FLT3 quickly changes conformation, and forms
a homodimer and exposes phosphoryl acceptor sites in TKD.17
Dimerization stabilizes this conformational change, which further
enhances activation of the receptor.18 The rate of FLT3 production,
the speed of degradation of the activated FLT3L–FLT3 complex,
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and the downstream effects of activation probably participate in a
complex feedback loop that regulates normal receptor activity.16 A
recent study also suggests that FLT3 is a hepatic lineage surface
marker.19 Its existence in oval cells further supports its crucial role
in hepatocyte development. However, the expression pattern of
FLT3 has not been investigated during liver regeneration.
Previously, our research team has examined the involvement of
the bcl-2 family of genes during liver regeneration,20 as prolifera-
tive and apoptotic mechanisms operate to provide a balance for the
survival. In this study we focused on the other aspect of this
complex process; proliferative response. We aimed to monitor the
expression of FLT3 at both mRNA and protein levels, in progenitor
cell-dependent liver regeneration. Other than the elucidation the
role of FLT3 in the proliferative response, we also aimed to isolate
and sequence the cDNA of rat FLT3 and monitor its tissue specific
expression.
Methods
Cloning of rat FLT3
The cDNA sequences of mouse FLT3 (NM 010229), human FLT3
(NM 004119), and predicted rat FLT3 (XM 221874) were aligned
using ClustalW tool (European Bioinformatics Institute; http://
www.ebi.ac.uk/clustalw/). We aimed to clone the full-length FLT3
cDNA in three overlapping fragments. The primers were designed
for the regions conserved among three species. The locations and
sequences of the cloning primers are shown in Fig. 1a and in
Table 1, respectively. Total cDNA from rat thymus was used as
template with the following PCR conditions: the initial denatur-
ation step at 95°C, followed by 45 cycles of denaturation for 60 s
at 94°C, annealing for 60 s at 55°C and extension for 60 s at 72°C.
A final extension at 72°C for 10 min was applied to all the reac-
tions. PCR products were electrophoresed and sequenced.
Animals
Male 9-week-old, 280–300 g Sprague–Dawley rats were used.
They were housed under controlled environmental conditions
(22°C) with a 12-h light-dark cycle in the animal holding facility
of the Department of Molecular Biology and Genetics at the
Bilkent University. All the animals received care according to the
criteria outlined in the ‘Guide for Care and Use of Laboratory
Animals’ prepared by the National Academy of Science, and this
study protocol complied with Bilkent University’s guidelines on
humane care and use of laboratory animals. The animals were
permitted unlimited access to food and water at all times.
Experimental groups
A 2-AAF solution (125 mg/mL) was prepared in DMSO, then
50 mg/kg 2-AAF was administrated to each rat for 6 days. On the
seventh day, liver surgery was performed after injecting ketamine
(Ketalar, Pfizer, Istanbul, Turkey) subcutaneously at a dose of
30 mg/kg. In the partial hepatectomy (PH) group 70% of the liver
mass was resected,21 and in the sham hepatectomy (SH) group the
same surgical procedures were carried out but the liver lobes were
not resected. Operations were performed between 08:00 and
12:00 hours to minimize diurnal effects. After completion of the
procedure, the animals were placed under a lamp to prevent hypo-
thermia and then put into cages (one animal per cage) with con-
tinuous supply of food and water.
Three randomly selected animals from the PH and SH groups
were killed by cervical dislocation at 2 h, 12 h, 18 h, 24 h and
7 days after the operation. The remnant liver lobes were excised
and washed in DMEM medium, then immediately frozen in liquid
nitrogen.
Total RNA isolation and reverse transcription
Total RNA was isolated from tissue samples using Tripure solution
(Roche-Boehringer Mannheim, Germany) according to the manu-
facturer’s protocol. The integrity of the isolated RNA samples was
determined by denaturing- (formaldehyde-) agarose gel electro-
phoresis. The cDNA samples were synthesized from the total RNA
samples with the RevertAid First Strand cDNA Synthesis Kit
(Fermentas, Burlington, ON, Canada) according to the manufac-
turer’s protocol.
Real-time RT-PCR
The primers that were used for real-time RT-PCR are shown in
Table 2. Before performing the real-time RT-PCR reactions for
experimental samples, the amplification efficiencies of FLT3 and
cyclophilin (CYC; internal control) primers were calculated using
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Figure 1 (a) Exons of FLT3 and location of cloning primers. F1e-F1 and
R1 primers (blue) were used for amplifying Part 1, F2 and R2 primers
(red) were used for amplifying Part 2, and F3 and R3 primers (green)
were used for amplifying Part 3. (b) Agarose gel electrophoresis of PCR
products of Part 1, Part 2 and Part 3. All three fragments were amplified
from thymus cDNA. 100 bp DNA Ladder Plus was used as the molecu-
lar size marker.
Table 1 Primers used for cloning of rat FLT3
Primer Sequence
F1e 5′-TCT AGA ATG CGG GCG TTG CG-3′
F1 5′-CTG CTT GTT GTT TTG TCA GTA ATG-3′
R1 5′-GGT TGT TCT TAT GAT CGC AAA ATT-3′
F2 5′-ACA GCG TTG GTG ACC ATC CTA-3′
R2 5′-GAA TTG AAT TCC CAT TGA ACC CTG-3′
F3 5′-GTT CAA TGG GAA TTC AAT TCA TTC-3′
R3 5′-TCT AGA CTA ACT TTT CTC TGT GAG-3′
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for 10 min, followed by 50 (for FLT3) and 32 (for CYC) cycles of
denaturation for 60 s for FLT3 and 30 s for CYC at 94°C, anneal-
ing for 60 s at 60°C for FLT3 and 30 s at 55°C for CYC and
extension for 60 s for FLT3 and 30 s for CYC at 72°C. A final
extension at 72°C for 10 min was applied to all the reactions. The
real-time PCR reactions followed by a melting curve analysis were
carried out in iCycler (Bio-Rad, Hercules, CA, USA). The thresh-
old cycle (Ct) values for FLT3 and CYC for each of the 2-AAF-
treated SH and PH samples (normal liver, 0 h, 2 h, 12 h, 18 h, 24 h
and 7 days) were obtained. Fold change in the expression of FLT3
was estimated based on the comparative Ct (2–DDCt) method22 using
the normal liver sample as calibrator.
Protein isolation and quantification
For protein isolation, 100 mg of tissue samples were homogenized
in 1 mL of Camiolo Buffer and centrifuged at 12 000 g for 20 min
at 4°C. In order to check the equal loading, 12 mg of protein
samples were run on 8% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). A 5 mL PageRuler Prestained
Protein Ladder (Fermentas) was used as protein molecular weight
marker. After electrophoresis, the gel was stained with Coomassie
staining solution for 5 min and then destained with Coomassie
destaining solution overnight.
Western blotting
The proteins were separated on 8% SDS-PAGE and transferred to
polyvinylidene fluoride membrane. The membrane was blocked
with blocking solution for 1 h at room temperature. FLT3 antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) was diluted to
a concentration of 0.2 mg/mL in blocking solution, and the mem-
brane was incubated in antibody solution for 1 h at room tempera-
ture. Then, the membrane was incubated in 1/5000 diluted
antirabbit-horseradish peroxidase (HRP; Sigma, St Louis, MO,
USA) secondary antibody solution for 1 h at room temperature.
Finally, the membrane was incubated with ECL Plus Detection
Reagent (Amersham Biosciences, Piscataway, NJ, USA) for 5 min
and placed in a X-ray film cassette and developed.
Immunohistochemistry
Paraffin sections (5 mm thick) were incubated for 30 min in 0.3%
hydrogen peroxide in methanol to quench endogenous peroxidase
activity. After washing three times with phosphate-buffered saline
(PBS) for 10 min each, slides were incubated with preblocking
serum (normal goat serum 1.5%, bovine serum albumin 2%,
triton-X 0.1%) for 1 h at room temperature. Primary antibody of
FLT3 (Santa Cruz Biotechnology) was applied at a concentration
of 5 mg/mL in preblocking solution and kept at 4°C for overnight.
After washing three times with PBS, tissue sections were incu-
bated for 15 min each with biotinylated antimouse and antirabbit
Ig and streptavidin-HRP (all Dako, Glostrup, Denmark) at room
temperature. After washing 10 min with PBS, slides were rinsed in
0.5% Triton-X 100/PBS for 30 s. Color developments were
achieved by incubation with Liquid DAB+ (Dako). The slides
were then counterstained with hematoxylin and mounted using
Faramount Aqueous Mounting Medium (Dako).
Results
Cloning of rat FLT3
We aimed to clone rat homolog of FLT3 cDNA in three overlap-
ping fragments (Part 1, Part 2, and Part 3) from thymus (Fig. 1a).
However, cloning of part 1, the most 5′ fragment, could not be
accomplished using F1e and R1 primer pair. Therefore, a second
forward primer, F1 that recognizes a sequence located approxi-
mately 35 base pairs downstream of the coding region was
designed. All three fragments were amplified individually
(Fig. 1b); sequencing of these fragments revealed a partial cDNA
sequence for rat homolog of FLT3 gene (Fig. 2a). Alignment of
this sequence with mouse FLT3 (NM010229) and human FLT3
(NM004119) by BCM Search Launcher: Multiple Sequence
Alignments tool (Baylor College of Medicine) showed 90%
homology with mouse and 81% homology with human sequences
(Fig. 2b).
Tissue specific expression of rat FLT3
We analyzed the expression of FLT3 in different rat tissues at both
the mRNA and the protein levels. Our results showed that FLT3
mRNA was expressed variably in the entire tissues examined
(Fig. 3). In uterus, spleen, cerebellum and lungs, the expression of
FLT3 was high, whereas in brain, ovary and skeletal muscle FLT3
level was found to be relatively low. In contrast to the presence of
FLT3 mRNA in heart and kidney (Fig. 3), we did not detect any
expression of FLT3 at the protein level in these tissues (Fig. 4a,
first two lanes). Our Western blot experiments revealed the pres-
ence of FLT3 protein in other tissues (Fig. 4a).
Expression of FLT3 mRNA during progenitor
cell-dependent liver regeneration
The primer efficiencies of FLT3 and CYC were 1.95 and 1.90,
respectively. As these values did not differ greatly from each other
and approximated the expected value, the 2–DDCt formula was used
in calculation of the fold differences among groups. Our real-time
PCR results showed that FLT3 mRNA expression decreased at all
time points in the PH groups compared to that of normal liver
during progenitor cell-dependent liver regeneration (Fig. 5a). The
expression of FLT3 also decreased in the SH groups when com-
pared to normal liver although not to the extent observed in the PH
groups, except at the 24 h after the operation. When we examined
the expression in liver regeneration after 70% hepatectomy in rats
without 2-AAF administration, we observed a similar pattern to
the PH group, except at 2 h after PH (Fig. 5b). The difference
between these two groups may reflect the effect of 2-AAF.
Table 2 Primers used for real-time RT-PCR
Primer Sequence
FLT3 Forward 5′-TGG TGA CCT GCT CAA CTA CCT A-3′
FLT3 Reverse 5′-AGT CAC AGA TCT TCA CCA CCT T-3′
CYC Forward 5′-GGG AAG GTG AAA GAA GGC AT-3′
CYC Reverse 5′-GAG AGC AGA GAT TAC AGG GT-3′
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Figure 2 (a) Partial sequence of rat homolog of FLT3 cDNA. (b) Comparison of rat, mouse (NM 010229) and human (NM 004119) FLT3 cDNAs. The
regions that are conserved in all three species are shown in black blocks.
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Expression of FLT3 protein in progenitor
cell-dependent liver regeneration
Our Western blotting data with anti-FLT3 antibody showed rela-
tively constant levels of FLT3 protein during the early stages of
liver regeneration compared to that of normal liver, but its level
decreased starting from 18 h through to 7 days postoperatively
(Fig. 6a). In contrast, there was an increase at 18 h and 24 h in the
SH groups (Fig. 6a).
As we observed FLT3 protein in all samples, next we per-
formed immunohistochemistry to examine the cellular location of
FLT3 protein in PH and SH groups (Fig. 7). In parallel with
Western blot, FLT3 protein was detected in both PH (Fig. 7f–j) and
SH groups (Fig. 7k–o) by immunohistochemistry. Interestingly,
the cellular localization of FLT3 was different among our samples
(Fig. 8). In the SH groups (Fig. 8c,d) and the early PH groups
(Fig. 8a), FLT3 protein showed a membranous staining, but in the
late PH groups the staining was mainly seen in the cytoplasm
(Fig. 8b).
Discussion
From the work described in this article we were able to achieve the
following: (i) cloning and characterization of rat FLT3 cDNA,
which showed extremely high homology with mouse and to a
lesser extent with human; (ii) possible explanation of the mecha-
nism of FLT3 during progenitor-dependent liver regeneration.
Three different types of cells are believed to regenerate hepato-
cytes: hepatocytes, oval cells and bone marrow derived stem
cells.23 Among these cell types, there has been debate on the role
of bone marrow derived stem cells. These are multipotent cells and
have a very long proliferation potential. However, they rarely
constitute more than 1% of the total hepatocytes in humans,24 and
their role in rodents is still controversial, if any.25 In contrast, the
involvement of hepatocytes and oval cells during liver regenera-
tion is well established.13 If the liver damage is less severe, mature
hepatocytes respond rapidly to liver injury.24 Finally, oval cells are
also the source of new hepatocytes, and these cells are activated
when the liver damage is extensive and chronic, or if proliferation
of hepatocytes is inhibited. Oval cell precursors located in the
canal of Hering represent likely candidates for liver-repopulating
stem cells, and can be considered a facultative liver stem
cell.24,26,27
Oval cells express not only markers of the hepatocyte and bile
duct lineage but also markers of hematopoietic stem cells such as
FLT3.28,29 As FLT3 is a subclass III RTK, it is logical to assign a
role to FLT3 during liver regeneration. However, its expression








Figure 3 Expression of (a) FLT3 and (b) CYC
mRNA in rat tissues. M, 100 bp DNA Ladder
Plus; (–), negative control.
(a)
Heart Kidney Thymus Liver Uterus Lung Spleen Ovary Brain Testicle
(b)
Figure 4 Expression of FLT3 protein in rat
tissues by (a) Western blotting with anti-FLT3
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Figure 5 Real-time PCR of FLT3 mRNA during progenitor-dependent
liver regeneration in (a) 2-AAF-treated and (b) untreated rats after 70%
partial hepatectomy (PH). Expression of FLT3 in regenerating () sham
hepatectomy (SH) and ( ) PH livers was measured at different time
points and compared to normal control liver.
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aimed to investigate the expression profile of FLT3 during pro-
genitor cell-dependent rat liver regeneration, which was triggered
by 2-AAF-treatment in combination with PH. Our results showed
that there was a reduction at the mRNA level of FLT3 after PH. In
both the PH and SH groups, the anesthetic used might have had an
effect on the expression profile of liver cells. The reduction in the
mRNA transcript level of FLT3 in the PH groups also may be
related to the massive loss of cells. The observed pattern of FLT3
(a)
NL 0h 2 h 12 h 18 h
SH-AAF PH-AAF
24 h 48 h 7 d 2 h 12 h 18 h 24 h 48 h 7 d
(b)
Figure 6 Expression of proteins extracted
from 2-AAF-treated sham hepatectomy (SH)
and partial hepatectomy (PH) groups by (a)
Western blotting with anti-FLT3 antibody and



























Figure 7 Immunohistochemistry of 2-AAF-
treated sham hepatectomy (SH) and partial
hepatectomy (PH) groups: (a–e) untreated
(control) PH group, (f–j) PH group; and (k–o)
SH group.
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expression and lack of a tight correlation between the mRNA and
protein levels of FLT3 suggests that an increase in FLT3 expres-
sion may not always be a prominent feature of liver regeneration.
In addition, the FLT3 protein level was almost equal in all groups.
Our findings indicated that post-translational mechanisms, such
as translocation of FLT3 between cellular compartments, might
also play important roles. Therefore, we performed immunohis-
tochemistry experiments in order to examine the localization of
FLT3 protein in different experimental groups. Our results
revealed that in all 2-AAF-treated SH groups and in early groups
of 2-AAF-treated PH samples (2 h, 12 h and 18 h), FLT3 expres-
sion was seen exclusively on the plasma membrane. Interestingly,
in later AAF-treated PH groups, especially in the 7 days after PH
group, there was strong cytoplasmic staining. The change in the
cellular localization of the FLT3 during early and late stages of
liver regeneration strongly suggests alterations in the activation
status of the FLT3 receptor. Under normal conditions (normal liver
and SH groups), FLT3 resides in the plasma membrane in an
inactive monomeric form. However, when liver injury occurs and
the liver undergoes a regeneration process, FLT3 is activated and
internalized in order to relay signals for proliferative events. Acti-
vation and internalization of receptors ultimately results in the
degradation of receptors as shown previously.17 Therefore, the
cytoplasmic staining of FLT3 protein in late 2-AAF-treated PH
groups may reflect the presence of internalized FLT3 receptors.
Western blotting results of the 24 h and 7 days PH groups in which
FLT3 protein levels were relatively lower support this model of
increased FLT3 receptor degradation.
Taking all our findings together, a likely scenario would be as
follows: under normal conditions (normal liver and SH groups),
FLT3 is expressed on the plasma membrane in its monomeric
inactive form. The situation is also the same in the early PH
groups. However, in the late PH groups, in addition to other
factors, FLT3 is activated and internalized in order to potentiate
cellular proliferation.
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